IUI vs IVF: How to Know When It’s Time to Escalate

If you’re reading this, you’re probably somewhere in the middle: you’ve tried IUI (or you’re being offered it), and you’re wondering whether it makes sense to keep going or whether it’s time to move to IVF. Maybe your RE has suggested “a few more cycles” and you’re not sure if that’s sound medicine or expensive optimism.

This is one of the most consequential decisions in fertility treatment, and it deserves a framework—not just a recommendation from a clinic that may have financial incentives in either direction. Here’s how to think about it.

The Fundamental Difference

IUI (intrauterine insemination) places washed, concentrated sperm directly into the uterus, timed to ovulation. It improves the odds of natural conception but cannot bypass structural problems, severe sperm issues, or fundamentally change egg quality.

IVF (in vitro fertilization) retrieves eggs, fertilizes them in a lab, cultures the resulting embryos, and transfers the best candidate back into the uterus. It controls every step of the process that IUI leaves to chance.

The success rate difference is significant. IUI success rates run 10–20% per cycle for women under 35, dropping to 5% or less per cycle for women over 40. IVF success rates run 40–55% per transfer for women under 35, and 20–35% for women 35–40. The gap widens with age, diagnosis severity, and repeated failures.

The Decision Framework: When to Stay, When to Escalate

Continue IUI If…

You are under 35 with unexplained infertility or mild male factor and have completed fewer than three medicated IUI cycles. In this scenario, the cumulative pregnancy rate across 3–4 stimulated IUI cycles can reach 20–30%, and the per-cycle cost is dramatically lower than IVF. The American Society for Reproductive Medicine (ASRM) supports stimulated IUI as a reasonable first-line option for this population.

You have open fallopian tubes (confirmed by HSG or hysteroscopy), adequate ovarian reserve (AMH above 1.0 ng/mL, antral follicle count of 8+), and at least 5 million total motile sperm post-wash. These are the minimum parameters where IUI has a realistic chance of working.

Escalate to IVF If…

You’ve completed 3–4 IUI cycles without success. This is the most commonly cited threshold in the literature. After three or four cycles, the cumulative success curve flattens dramatically. Each additional IUI cycle adds very little probability while accumulating cost and time. The evidence-based move is to switch to a treatment with a much higher per-cycle success rate.

You’re over 38. Age is the strongest single predictor of fertility treatment outcomes. For women over 38, IUI success rates drop sharply, and the time spent on low-probability IUI cycles has an opportunity cost: every month spent on a 5–10% chance is a month your egg reserve continues to decline. Many REs recommend proceeding directly to IVF for patients over 38, bypassing IUI entirely.

You have a diagnosis that IUI can’t meaningfully address. Blocked or damaged fallopian tubes (IVF bypasses the tubes entirely), severe male factor infertility (total motile sperm count below 5 million, or high sperm DNA fragmentation), diminished ovarian reserve (low AMH, low AFC), moderate to severe endometriosis, or two or more prior pregnancy losses. For a deeper look at repeated loss, see our guide to recurrent pregnancy loss.

You need genetic testing. PGT-A testing (preimplantation genetic testing for aneuploidy) is only available through IVF. If you’re over 37, have a history of miscarriage, or carry a known genetic condition, PGT-A can significantly improve the per-transfer success rate by selecting chromosomally normal embryos.

Skip IUI Entirely and Go Straight to IVF If…

Some diagnoses and circumstances make IUI a detour, not a step. The ASRM and most reproductive endocrinologists recommend proceeding directly to IVF in cases of bilateral tubal occlusion, severe male factor (ICSI is required), patients over 40, very low ovarian reserve, or when family building requires donor eggs or gestational carriers.

The Real Barriers to Escalation

If the clinical framework were the only factor, most patients would escalate on schedule. But three non-medical barriers keep people in IUI cycles longer than the evidence supports:

Cost. IVF is dramatically more expensive per cycle, and many patients don’t have insurance coverage. The financial gap is real, but the relevant comparison is cost per live birth across the entire treatment journey, not cost per cycle. Four failed IUI cycles at $12,000 total, followed by IVF at $20,000, costs more than going to IVF directly after one or two IUI cycles. For patients for whom domestic IVF is cost-prohibitive, IVF abroad can reduce the financial barrier significantly.

Emotional investment. Each IUI cycle feels like progress. Switching to IVF can feel like admitting that the “easier” approach failed—even when the clinical reality is that IUI was never likely to work for your diagnosis. This is not a personal failure. It’s information.

Clinic incentives. Some clinics benefit financially from continuing IUI cycles. A responsible clinic will discuss escalation proactively based on your age, diagnosis, and cycle history. If your clinic isn’t initiating this conversation after 2–3 failed cycles, consider seeking a second opinion.

Questions to Ask Your RE at the Escalation Decision Point

When you’re deciding whether to continue IUI or move to IVF, ask your reproductive endocrinologist these specific questions: What is my per-cycle IUI success rate given my age, diagnosis, and prior results? What is the cumulative success rate if I do two more IUI cycles versus one IVF cycle? If IUI hasn’t worked in three cycles, what is the clinical rationale for continuing? Would you recommend IVF for someone with my exact profile, independent of cost? If I’m going to need IVF eventually, what am I gaining by doing more IUI first?

A good RE will answer these questions with data, not platitudes. If the answer to the last question is “not much,” you have your answer.

The Bottom Line

IUI is a legitimate, evidence-based fertility treatment—for the right patients, at the right time, for the right number of cycles. The mistake isn’t trying IUI. The mistake is staying on IUI past the point where the data supports it, because the per-cycle cost is lower or because escalation feels like giving up.

The Age Factor: A Decision Accelerator

Age doesn’t just affect success rates—it changes the speed at which you should move through the decision tree. For women under 35, trying 3–4 IUI cycles before escalating is reasonable because the per-cycle odds are meaningful and time is less pressured. But each year past 35 compresses the window, and by 38, every month spent on a low-probability treatment is a month of declining ovarian reserve that cannot be recovered.

The research supports age-adjusted escalation timelines. For women under 35 with no major structural or sperm issues, three to four medicated IUI cycles is a defensible starting point. For women 35–37, two to three cycles is more appropriate, with earlier transition if AMH is declining or response to stimulation is modest. For women 38–40, one to two cycles at most—and many reproductive endocrinologists recommend going directly to IVF. For women over 40, IUI is rarely recommended as a primary strategy because per-cycle success rates are so low that the time cost outweighs the financial savings.

These ranges are starting points, not rules. Your specific diagnosis, ovarian reserve markers, and partner’s sperm parameters all modify the calculus. But the overarching principle is clear: the older you are, the less time you should spend on lower-probability treatments.

What About Medicated vs. Unmedicated IUI?

Not all IUI cycles are equivalent. An unmedicated (natural cycle) IUI relies on your body’s single naturally selected egg and offers success rates of approximately 5–10% per cycle—barely above timed intercourse. A medicated IUI, using oral medications like letrozole or clomiphene citrate, stimulates the development of two to three follicles and roughly doubles the per-cycle success rate.

If you’ve been doing unmedicated IUI and haven’t succeeded, adding medication is a reasonable intermediate step before escalating to IVF. But if you’ve done three or more medicated IUI cycles without success, the marginal benefit of additional medicated cycles is minimal. The improvement to be had at that point comes from changing the treatment modality, not adjusting it.

Injectable gonadotropins (the same medications used in IVF stimulation, at lower doses) can further increase IUI success rates but also significantly increase the risk of high-order multiples (triplets or more). Most clinics that use injectable IUI monitor carefully and cancel cycles with more than three mature follicles. At the cost and complexity of injectable IUI, many REs argue you’re already bearing most of the burden of IVF without the control over embryo number that IVF provides.

The Emotional Calculus

The decision to escalate is not purely clinical. Each failed IUI cycle carries an emotional toll—the hope, the two-week wait, the negative test, the recalibration. Some patients find that the cumulative emotional cost of repeated IUI failures exceeds the financial cost difference between IUI and IVF.

There is no shame in choosing IVF earlier than strictly necessary from a clinical standpoint because the emotional burden of continued low-probability treatment is more than you want to carry. Your mental health is part of your fertility health. For more on managing the psychological dimension, see our guide to the emotional side of IVF.

The Bottom Line

IUI is a legitimate, evidence-based fertility treatment—for the right patients, at the right time, for the right number of cycles. The mistake isn’t trying IUI. The mistake is staying on IUI past the point where the data supports it, because the per-cycle cost is lower or because escalation feels like giving up.

Moving to IVF is not giving up. It’s choosing the treatment most likely to work for where you are now. For a clearer picture of what IVF involves, see our week-by-week IVF timeline and our breakdown of IVF success rates by age.